Prohibition Partners

Prohibition Partners · Free weekly briefing

International Cannabis Weekly

The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.

347

7 regions32 stories1 publisher14 countries

← №346All issues348

Top story

DEA set to approve cannabis rescheduling in the US

Eight months after the Department of Health and Human Services (HHS) recommended rescheduling cannabis to the DEA, the organisation has reportedly made its decision following sustained pressure from the Biden administration.

USRegulationlink no longer available

  1. 01

    Germany's Pillar 2 adult-use cannabis framework progressing ahead of schedule

    DERegulationlink no longer available

  2. 02

    MedMen files for bankruptcy amid US$411M debt woes

    USBusiness & Investmentlink no longer available

Europe

7 stories
  • Germany's predicted medical cannabis boom in full swing following CanG bill

    DEMedicallink no longer available

  • European cannabis leaders to take centre stage at Business of Cannabis Awards 2024

    EUEvents & Industrylink no longer available

  • Swiss initiative aims to embed cannabis legalisation into constitution

    CHRegulationlink no longer available

  • North Rhine-Westphalia interior minister opposes cannabis legalisation for police officers

    DERegulationlink no longer available

  • UK families turn to private clinics for medical cannabis as NHS access remains restricted

    GBMedicallink no longer available

  • Slovenia to hold referendum on cannabis cultivation legalisation

    SIAdult-uselink no longer available

  • European Cannabis Stocks Report

    Business of CannabisEvents & Industry

United States

6 stories
  • US cannabis industry set to deliver US$112.4 billion economic boost in 2024

    USBusiness & Investmentlink no longer available

  • Cannabis stocks surge on reports of DEA federal rescheduling approval

    USBusiness & Investmentlink no longer available

  • California and Missouri join states restricting Delta-8 and other 'diet weed' products

    USRegulationlink no longer available

  • New Hampshire GOP gubernatorial candidate opposes cannabis legalisation

    USRegulationlink no longer available

  • South Carolina medical cannabis bill unlikely to receive House vote before session ends

    USMedicallink no longer available

  • Study finds frequent cannabis use does not reduce motivation or cause paranoia

    Health & Sciencelink no longer available

Canada

6 stories
  • Canada's cannabis industry risks losing first-mover advantage to US after rescheduling

    CAUSBusiness & Investmentlink no longer available

  • Canopy Growth proceeds with Canopy USA plans after shareholder approval

    CAUSBusiness & Investmentlink no longer available

  • Regulated Canadian cannabis sales increase in February 2024 year-on-year

    CABusiness & Investmentlink no longer available

  • Decibel reports CA$1.8 million net loss in 2023 but increases export revenue

    CABusiness & Investmentlink no longer available

  • Ontario's online cannabis store to ship orders via Canada Post for CA$5 fee

    CAAdult-uselink no longer available

  • Canadian girls among highest rates of teen cannabis use, WHO study finds

    CAHealth & Sciencelink no longer available

LATAM & Caribbean

4 stories
  • Mexican senator Olga Sanchez to send adult-use cannabis legalisation bill to congress

    MXAdult-uselink no longer available

  • 'Cultivate Your Rights March' held in Chile for 18th consecutive year

    CLEvents & Industrylink no longer available

  • Clever Leaves announces voluntary delisting and SEC deregistration

    Business & Investmentlink no longer available

  • Cannabis consumption reportedly rising among school-age pupils in Bermuda

    BMHealth & Sciencelink no longer available

Africa & Middle East

2 stories
  • A cultivation area of over 2,552 hectares authorised in Morocco this year, compared to 286 hectares in 2023.

    MAHemp & CBDlink no longer available

  • InterCure announces FY2023 results with NIS₪356 million revenue

    ILBusiness & Investmentlink no longer available

APAC

1 story
  • Thailand's cannabis sector presents opportunities amid regulatory changes

    THRegulationlink no longer available

Oceania

3 stories
  • Cann Group takes steps to resume ASX trading as Q3 revenues decline and cash worsens

    AUBusiness & Investmentlink no longer available

  • Aurora launches premium dried flower products in Australia

    AUBusiness & Investmentlink no longer available

  • Medicinal Cannabis Industry Australia seeks board nominations

    AUEvents & Industrylink no longer available

Never miss an issue

International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.

From the research library

Global Medical Cannabis Market Review

14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.

From £1,265

View report